Citations (135)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
S. David Hudnall, Hailong Meng, Larissa Lozovatsky, Peining Li, Matthew Strout & Steven H. Kleinstein. (2016) Recurrent genetic defects in classical Hodgkin lymphoma cell lines. Leukemia & Lymphoma 57:12, pages 2890-2900.
Read now
Read now
Sakthi Rajendran, Weng Tong Ho & Herbert Schwarz. (2016) CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth. OncoImmunology 5:6.
Read now
Read now
Benjamin Rengstl, Frederike Schmid, Christian Weiser, Claudia Döring, Tim Heinrich, Kathrin Warner, Petra S. A. Becker, Robin Wistinghausen, Sima Kameh-Var, Eva Werling, Arne Billmeier, Christian Seidl, Sylvia Hartmann, Hinrich Abken, Ralf Küppers, Martin-Leo Hansmann & Sebastian Newrzela. (2016) Tumor-infiltrating HLA-matched CD4+ T cells retargeted against Hodgkin and Reed–Sternberg cells. OncoImmunology 5:6.
Read now
Read now
Marta Celegato, Cinzia Borghese, Naike Casagrande, Antonino Carbone, Alfonso Colombatti & Donatella Aldinucci. (2014) Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts. Leukemia & Lymphoma 55:1, pages 149-159.
Read now
Read now
Filippo Russo, Secondo Lastoria, Gino Svanera, Gaetana Capobianco, Anna de Chiara, Raffaele di Francia, Elisabetta Squame, Franco de Martinis & Antonio Pinto. (2007) Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma. Leukemia & Lymphoma 48:4, pages 723-730.
Read now
Read now
Brian F. Skinnider, Ursula Kapp & Tak W. Mak. (2002) The Role of Interleukin 13 in Classical Hodgkin Lymphoma. Leukemia & Lymphoma 43:6, pages 1203-1210.
Read now
Read now
AK Blystad, E Torlakovic, H Holte, S Kvaløy, E Lenschow & G Kvalheim. (2001) CD34 + cell enrichment depletes atypical CD30 + cells from PBPC grafts in patients with HD. Cytotherapy 3:4, pages 295-305.
Read now
Read now
Hans G. Drexler & Jun Minowada. (1998) History and Classification of Human Leukemia-Lymphoma Cell Lines. Leukemia & Lymphoma 31:3-4, pages 305-316.
Read now
Read now
Hans-Jürgen Gruss & Friedhelm Herrmann. (1996) CD30 Ligand, a Member of the TNF Ligand Superfamily, with Growth and Activation Control for CD30+ Lymphoid and Lymphoma Cells*. Leukemia & Lymphoma 20:5-6, pages 397-409.
Read now
Read now
Suzanne M. Gignac, Zhen-Bo Hu, Sabine A. Denkmann, Cord C. Uphoff & Hans G. Drexler. (1996) Esterase Isoenzyme Profiles of 255 Leukemia-Lymphoma Cell Lines from All Hematopoietic Cell Lineages. Leukemia & Lymphoma 22:1-2, pages 143-151.
Read now
Read now
Lorenzo Leoncini, Donatella Spina, Pauline Close, Tiziana Megha, Lorenzo Pacenti, Piero Tosi, Stefano Pileri, Antonio De Vivo, Rainer Kraft, Jean A. Laissue & Hans Cottier. (1996) Abortive Mitoses and Nuclear DNA Fragmentation in CD30+ Large Cells of Hodgkin's Disease. Leukemia & Lymphoma 22:1-2, pages 119-124.
Read now
Read now
Jan Delabie, Wing C. Chan, Dennis D. Weisenburger & Chris De Wolf-peeters. (1995) The Antigen-Presenting Cell Function of Reed-Sternberg Cells. Leukemia & Lymphoma 18:1-2, pages 35-40.
Read now
Read now
Articles from other publishers (123)
Jingxi Zhang, Zuoqiao Wu, Anton Savin, Mihye Yang, Ying-Han R. Hsu, Eugeniu Jantuan, Julinor T. C. Bacani & Robert J. Ingham. (2018) The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1. Scientific Reports 8:1.
Crossref
Crossref
Hans G. Drexler, Claudia Pommerenke, Sonja Eberth & Stefan Nagel. (2018) Hodgkin lymphoma cell lines: to separate the wheat from the chaff. Biological Chemistry 399:6, pages 511-523.
Crossref
Crossref
Clarissa D. OsswaldLinka Xie, Hanfeng Guan, Franziska HerrmannSarah M. PickMarion J. VogelFranziska GehringerFong Chun Chan, Christian Steidl, Thomas WirthAlexey Ushmorov. (2018) Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation. Blood 131:14, pages 1556-1567.
Crossref
Crossref
Ralf Küppers. 2018. Precision Molecular Pathology of Hodgkin Lymphoma. Precision Molecular Pathology of Hodgkin Lymphoma
35
57
.
Maryam Delforoush, Sara Strese, Malin Wickström, Rolf Larsson, Gunilla Enblad & Joachim Gullbo. (2016) In vitro and in vivo activity of melflufen (J1) in lymphoma. BMC Cancer 16:1.
Crossref
Crossref
Martin S. Staege. (2015) A short treatise concerning a musical approach for the interpretation of gene expression data. Scientific Reports 5:1.
Crossref
Crossref
Elisabeth Oelmann, Harald Stein, Wolfgang E. Berdel & Hermann Herbst. (2015) Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma. PLOS ONE 10:9, pages e0138747.
Crossref
Crossref
Martin S. Staege. (2015) A Multi-Component Model of Hodgkin's Lymphoma. PLOS ONE 10:4, pages e0124614.
Crossref
Crossref
Marta Celegato, Cinzia Borghese, Kazuo Umezawa, Naike Casagrande, Alfonso Colombatti, Antonino Carbone & Donatella Aldinucci. (2014) The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma. Cancer Letters 349:1, pages 26-34.
Crossref
Crossref
Benjamin Rengstl, Sebastian Newrzela, Tim Heinrich, Christian Weiser, Frederic B. ThalheimerFrederike Schmid, Kathrin WarnerSylvia Hartmann, Timm SchroederRalf Küppers, Michael A. Rieger & Martin-Leo Hansmann. (2013) Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed–Sternberg cells. Proceedings of the National Academy of Sciences 110:51, pages 20729-20734.
Crossref
Crossref
Jan M. Klein, Alexander Henke, Maike Sauer, Martina Bessler, Katrin S. Reiners, Andreas Engert, Hinrich P. Hansen & Elke Pogge von Strandmann. (2013) The Histone Deacetylase Inhibitor LBH589 (Panobinostat) Modulates the Crosstalk of Lymphocytes with Hodgkin Lymphoma Cell Lines. PLoS ONE 8:11, pages e79502.
Crossref
Crossref
V Bohle, C Döring, M-L Hansmann & R Küppers. (2012) Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma. Leukemia 27:3, pages 671-679.
Crossref
Crossref
Daniela BuglioSangeetha Palakurthi, Kate Byth, Francisco Vega, Dorin Toader, Jamal Saeh, Sattva S. NeelapuAnas Younes. (2012) Essential role of TAK1 in regulating mantle cell lymphoma survival. Blood 120:2, pages 347-355.
Crossref
Crossref
Anna Swanson, Eleanor Cheadle, David Gilham, Dorothy Crawford, Simon Talbot & Ingo Johannessen. (2012) Rejection of Experimental Hodgkins Lymphoma by T-Cells Engineered with a CD19 Chimeric Antigen Receptor. Journal of Cancer Therapy 03:05, pages 553-561.
Crossref
Crossref
E Derenzini, M Lemoine, D Buglio, H Katayama, Y Ji, R E Davis, S Sen & A Younes. (2011) The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. Blood Cancer Journal 1:12, pages e46-e46.
Crossref
Crossref
Ádám Jóna, Noor Khaskhely, Daniela Buglio, Jessica A. Shafer, Enrico Derenzini, Catherine M. Bollard, L. Jeffrey Medeiros, Árpád Illés, Yuan Ji & Anas Younes. (2011) The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors. Experimental Hematology 39:10, pages 1007-1017.e1.
Crossref
Crossref
Ingrid Glimelius, Jenny Rubin, Marie Fischer, Daniel Molin, Rose-Marie Amini, Per Venge & Gunilla Enblad. (2011) Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines. Experimental Hematology 39:8, pages 850-858.
Crossref
Crossref
Donatella Aldinucci, Marta Celegato, Cinzia Borghese, Alfonso Colombatti & Antonino Carbone. (2011) IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion. British Journal of Haematology 152:2, pages 182-190.
Crossref
Crossref
Daniela Buglio, Vidya Mamidipudi, Noor M. Khaskhely, Helen Brady, Carla Heise, Jeffrey Besterman, Robert E. Martell, Kyle MacBeth & Anas Younes. (2010) The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism. British Journal of Haematology 151:4, pages 387-396.
Crossref
Crossref
Annunziata Gloghini, Daniela Buglio, Noor M. Khaskhely, Georgios Georgakis, Robert Z. Orlowski, Sattva S. Neelapu, Antonino Carbone & Anas Younes. (2009) Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors. British Journal of Haematology 147:4, pages 515-525.
Crossref
Crossref
D Baus, F Nonnenmacher, S Jankowski, C Döring, C Bräutigam, M Frank, M-L Hansmann & E Pfitzner. (2009) STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line. Leukemia 23:10, pages 1885-1893.
Crossref
Crossref
Annette Lake, Lesley A. Shield, Pablo Cordano, Daniel T.Y. Chui, Julie Osborne, Shauna Crae, Katherine S. Wilson, Sabrina Tosi, Samantha J.L. Knight, Stefan Gesk, Reiner Siebert, Ron T. Hay & Ruth F. Jarrett. (2009)
Mutations of
NFKBIA
, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases
. International Journal of Cancer 125:6, pages 1334-1342.
Crossref
Crossref
Lara Cattaruzza, Annunziata Gloghini, Karin Olivo, Raffaele Di Francia, Debora Lorenzon, Rosaria De Filippi, Antonino Carbone, Alfonso Colombatti, Antonio Pinto & Donatella Aldinucci. (2009) Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. International Journal of Cancer 125:5, pages 1092-1101.
Crossref
Crossref
Roland SchmitzJens StanelleMartin-Leo HansmannRalf Küppers. (2009) Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma. Annual Review of Pathology: Mechanisms of Disease 4:1, pages 151-174.
Crossref
Crossref
Daniela Buglio, Georgios V. Georgakis, Shino Hanabuchi, Kazuhiko Arima, Noor M. Khaskhely, Yong-Jun Liu & Anas Younes. (2008) Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. Blood 112:4, pages 1424-1433.
Crossref
Crossref
Donatella Aldinucci, Debora Lorenzon, Lara Cattaruzza, Antonio Pinto, Annunziata Gloghini, Antonino Carbone & Alfonso Colombatti. (2008) Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. International Journal of Cancer 122:4, pages 769-776.
Crossref
Crossref
S Tedoldi, A Mottok, J Ying, JC Paterson, Y Cui, F Facchetti, JHJM van Krieken, M Ponzoni, S Özkal, N Masir, Y Natkunam, SA Pileri, M-L Hansmann, DY Mason, Q Tao & T Marafioti. (2007) Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. The Journal of Pathology 213:4, pages 429-440.
Crossref
Crossref
Elias Drakos, Athanasios Thomaides, L. Jeffrey Medeiros, Jiang Li, Vasiliki Leventaki, Marina Konopleva, Michael Andreeff & George Z. Rassidakis. (2007) Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma. Clinical Cancer Research 13:11, pages 3380-3387.
Crossref
Crossref
April ChiuWeifeng XuBing HeStacey R. DillonJane A. GrossEric SieversXugang QiaoPaul SantiniElizabeth HyjekJoong-won LeeEthel Cesarman, Amy ChadburnDaniel M. KnowlesAndrea Cerutti. (2006) Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 109:2, pages 729-739.
Crossref
Crossref
Yasodha NatkunamEric D. HsiPatricia AounShuchun ZhaoPaul ElsonBrad PohlmanHina NaushadMartin BastRonald LevyIzidore S. Lossos. (2006) Expression of the human germinal center–associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. Blood 109:1, pages 298-305.
Crossref
Crossref
Nadine S. I. Aguilera, Jian Chen, Karen E. Bijwaard, Alison E. Director-Myska, Carol L. Barekman, Carl Millward, Jack Lichy & Susan L. Abbondanzo. (2006) Gene Rearrangement and Comparative Genomic Hybridization Studies of Classic Hodgkin Lymphoma Expressing T-Cell Antigens. Archives of Pathology & Laboratory Medicine 130:12, pages 1772-1779.
Crossref
Crossref
Elisabeth Puchhammer-Stöckl & Irene Görzer. (2006) Cytomegalovirus and Epstein-Barr virus subtypes—The search for clinical significance. Journal of Clinical Virology 36:4, pages 239-248.
Crossref
Crossref
Alexey UshmorovFrank LeithäuserOlena SakkAndreas WeinhaüselSergey W. PopovPeter MöllerThomas Wirth. (2006) Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 107:6, pages 2493-2500.
Crossref
Crossref
Georgios V. Georgakis, Yang Li, Georgios Z. Rassidakis, Hector Martinez-Valdez, L. Jeffrey Medeiros & Anas Younes. (2006) Inhibition of Heat Shock Protein 90 Function by 17-Allylamino-17-Demethoxy-Geldanamycin in Hodgkin's Lymphoma Cells Down-Regulates Akt Kinase, Dephosphorylates Extracellular Signal–Regulated Kinase, and Induces Cell Cycle Arrest and Cell Death. Clinical Cancer Research 12:2, pages 584-590.
Crossref
Crossref
Craig H. Moskowitz. 2006. Oncology. Oncology
1240
1255
.
Georgios V. Georgakis, Yang Li, Georgios Z. Rassidakis, L. Jeffrey Medeiros, Gordon B. Mills & Anas Younes. (2005) Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. British Journal of Haematology 0:0, pages 051220022257008.
Crossref
Crossref
Georgios V. Georgakis, Yang Li, Robin Humphreys, Michael Andreeff, Susan O'Brien, Mamoun Younes, Antonino Carbone, Vivian Albert & Anas Younes. (2005) Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. British Journal of Haematology 130:4, pages 501-510.
Crossref
Crossref
Md. Zahidunnabi Dewan, Mariko Watanabe, Sunjida Ahmed, Kazuo Terashima, Sankichi Horiuchi, Tetsutaro Sata, Mitsuo Honda, Mamoru Ito, Toshiki Watanabe, Ryouichi Horie & Naoki Yamamoto. (2005) Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammacnull mice. Cancer Science 96:8, pages 466-473.
Crossref
Crossref
Marina Konopleva, Elena Elstner, Teresa J. McQueen, Twee Tsao, Andrey Sudarikov, Wei Hu, Wendy D. Schober, Rui-Yu Wang, David Chism, Steven M. Kornblau, Anas Younes, Steven J. Collins, H. Phillip Koeffler & Michael Andreeff. (2004) Peroxisome proliferator-activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Molecular Cancer Therapeutics 3:10, pages 1249-1262.
Crossref
Crossref
Bei Zheng, Georgios V. Georgakis, Yang Li, Alok Bharti, David McConkey, Bharat B. Aggarwal & Anas Younes. (2004) Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors. Clinical Cancer Research 10:9, pages 3207-3215.
Crossref
Crossref
Arjan Diepstra, Ewerton M. Maggio, Anke van den Berg & Sibrand Poppema. 2004. Cancer Immunotherapy at the Crossroads. Cancer Immunotherapy at the Crossroads
315
334
.
Bertram Schnitzer & Riccardo Valdez. 2004. Hematopathology in Oncology. Hematopathology in Oncology
259
290
.
Ofra Ohana-Malka, Daniel Benharroch, Noah Isakov, Isebrand Prinsloo, Giora Shubinsky, Martin Sacks & Jacob Gopas. (2003) Selectins and anti-CD15 (Lewis x/a) antibodies transmit activation signals in Hodgkin's lymphoma–derived cell lines. Experimental Hematology 31:11, pages 1057-1065.
Crossref
Crossref
Florian Emmerich, Sebastian Theurich, Michael Hummel, Antje Haeffker, Magnus S Vry, Konstanze Döhner, Kurt Bommert, Harald Stein & Bernd Dörken. (2003) Inactivating I kappa B epsilon mutations in Hodgkin/Reed–Sternberg cells. The Journal of Pathology 201:3, pages 413-420.
Crossref
Crossref
Daniel T.Y. Chui, David Hammond, Margaret Baird, Lesley Shield, Robert Jackson & Ruth F. Jarrett. (2003) Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes, Chromosomes and Cancer 38:2, pages 126-136.
Crossref
Crossref
Bei Zheng, Paolo Fiumara, Yang V. Li, Georgios Georgakis, Virginia Snell, Mamoun Younes, Jean Nicolas Vauthey, Antonino Carbone & Anas Younes. (2003) MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 102:3, pages 1019-1027.
Crossref
Crossref
Im-Soon Lee, Seok Hyung Kim, Hyung Geun Song & Seong Hoe Park. (2003) The Molecular Basis for the Generation of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Lymphoma. International Journal of Hematology 77:4, pages 330-335.
Crossref
Crossref
Ines Schwering, Andreas Bräuninger, Verena Distler, Julia Jesdinsky, Volker Diehl, Martin-Leo Hansmann, Klaus Rajewsky & Ralf Küppers. (2003) Profiling of Hodgkin’s Lymphoma Cell Line L1236 and Germinal Center B Cells: Identification of Hodgkin’s Lymphoma-specific Genes. Molecular Medicine 9:3-4, pages 85-95.
Crossref
Crossref
Meztli Arguello, Marco Sgarbanti, Eduardo Hernandez, Yael Mamane, Sonia Sharma, Marc Servant, Rongtuan Lin & John Hiscott. (2003) Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 22:7, pages 964-973.
Crossref
Crossref
Ines SchweringAndreas BräuningerUlf KleinBerit JungnickelMarianne TinguelyVolker DiehlMartin-Leo HansmannRiccardo Dalla-FaveraKlaus RajewskyRalf Küppers. (2003) Loss of the B-lineage–specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101:4, pages 1505-1512.
Crossref
Crossref
Ralf Küppers, Ulf Klein, Ines Schwering, Verena Distler, Andreas Bräuninger, Giorgio Cattoretti, Yuhai Tu, Gustavo A. Stolovitzky, Andrea Califano, Martin-Leo Hansmann & Riccardo Dalla-Favera. (2003) Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. Journal of Clinical Investigation 111:4, pages 529-537.
Crossref
Crossref
Ralf Küppers, Ulf Klein, Ines Schwering, Verena Distler, Andreas Bräuninger, Giorgio Cattoretti, Yuhai Tu, Gustavo A. Stolovitzky, Andrea Califano, Martin-Leo Hansmann & Riccardo Dalla-Favera. (2003) Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. Journal of Clinical Investigation 111:4, pages 529-537.
Crossref
Crossref
H G Drexler, W G Dirks, Y Matsuo & R A F MacLeod. (2003) False leukemia–lymphoma cell lines: an update on over 500 cell lines. Leukemia 17:2, pages 416-426.
Crossref
Crossref
Donatella Aldinucci, Dalisa Poletto, Paola Nanni, Massimo Degan, Annunziata Gloghini, Raffaele Di Francia, Stefania Russo, Antonino Carbone, Antonio Pinto & Valter Gattei. (2002) Hodgkin and Reed-Sternberg cells express functional c-kit receptors and interact with primary fibroblasts from Hodgkin's disease-involved lymph nodes through soluble and membrane-bound stem cell factor. British Journal of Haematology 118:4, pages 1055-1064.
Crossref
Crossref
H Kashkar, M Krönke & J M Jürgensmeier. (2002) Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. Cell Death & Differentiation 9:7, pages 750-757.
Crossref
Crossref
Brian F. SkinniderTak W. Mak. (2002) The role of cytokines in classical Hodgkin lymphoma. Blood 99:12, pages 4283-4297.
Crossref
Crossref
Ewerton M. Maggio, Anke Van den Berg, Lydia Visser, Arjan Diepstra, Joust Kluiver, Roelke Emmens & Sibrand Poppema. (2002) Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical hodgkin lymphomas. International Journal of Cancer 99:5, pages 665-672.
Crossref
Crossref
Matjaz Zwitter, Joel R Cohen, Ann Barrett & Elizabeth D Robinton. (2002) Dorothy Reed and Hodgkin’s disease: a reflection after a century. International Journal of Radiation Oncology*Biology*Physics 53:2, pages 366-375.
Crossref
Crossref
Elisabeth Devilard, François Bertucci, Pascal Trempat, Reda Bouabdallah, Béatrice Loriod, Aurélia Giaconia, Pierre Brousset, Samuel Granjeaud, Catherine Nguyen, Daniel Birnbaum, Françoise Birg, Remi Houlgatte & Luc Xerri. (2002) Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. Oncogene 21:19, pages 3095-3102.
Crossref
Crossref
Gisele W.B. Colleoni, Paola Capodieci, Satish Tickoo, Jeffrey Cossman, Daniel A. Filippa & Marc Ladanyi. (2002) Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma. Human Pathology 33:5, pages 496-502.
Crossref
Crossref
D Re, C Wickenhauser, T Ahmadi, E Buchdunger, M Kochanek, V Diehl & J Wolf. (2002) Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease. British Journal of Cancer 86:8, pages 1333-1335.
Crossref
Crossref
Donatella Aldinucci, Dalisa Poletto, Annunziata Gloghini, Paola Nanni, Massimo Degan, Tiziana Perin, Paola Ceolin, Francesca Maria Rossi, Valter Gattei, Antonino Carbone & Antonio Pinto. (2002) Expression of Functional Interleukin-3 Receptors on Hodgkin and Reed-Sternberg Cells. The American Journal of Pathology 160:2, pages 585-596.
Crossref
Crossref
Elisabeth OelmannHermann HerbstMichael ZühlsdorfOliver AlbrechtAnnette NolteChristiane SchmitmannOliver ManzkeVolker DiehlHarald SteinWolfgang E. Berdel. (2002) Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99:1, pages 258-267.
Crossref
Crossref
Ralf Küppers. 2002.
277
312
.
Roderick A.F. MacLeod & Hans G. Drexler. 2002. Human Cell Culture. Human Cell Culture
371
397
.
Andrea Staratschek-Jox, Jürgen Wolf & Volker Diehl. 2002. Human Cell Culture. Human Cell Culture
339
353
.
Hans G. Drexler & Jun Minowada. 2002. Human Cell Culture. Human Cell Culture
1
18
.
Ed SatterwhiteTakashi SonokiTony G. WillisLana HarderRachael NowakEmma L. ArriolaHui LiuHelen P. PriceStefan GeskDoris SteinemannBrigitte SchlegelbergerDavid G. OscierReiner SiebertPhilip W. TuckerMartin J. S. Dyer. (2001) The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98:12, pages 3413-3420.
Crossref
Crossref
Paolo FiumaraFernando CabanillasAnas Younes. (2001) Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers. Blood 98:9, pages 2877-2878.
Crossref
Crossref
Paolo FiumaraVirginia SnellYang LiAsok MukhopadhyayMamoun YounesAnn Marie GillenwaterFernando CabanillasBharat B. AggarwalAnas Younes. (2001) Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines. Blood 98:9, pages 2784-2790.
Crossref
Crossref
Yasuo Oshima & Raj K. Puri. (2001) Suppression of an IL-13 Autocrine Growth Loop in a Human Hodgkin/Reed-Sternberg Tumor Cell Line by a Novel IL-13 Antagonist. Cellular Immunology 211:1, pages 37-42.
Crossref
Crossref
Johannes Irsch, Jürgen Wolf, Hans Tesch, Volker Diehl, Andreas Radbruch & Andrea Staratschek-Jox. (2001) Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell lines. British Journal of Haematology 113:3, pages 785-793.
Crossref
Crossref
Shiyong Li, Douglas T. Ross, Marshall E. Kadin, Patrick O. Brown & Mariusz A. Wasik. (2001) Comparative Genome-Scale Analysis of Gene Expression Profiles in T Cell Lymphoma Cells during Malignant Progression Using a Complementary DNA Microarray. The American Journal of Pathology 158:4, pages 1231-1237.
Crossref
Crossref
. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
699
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
484
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
482
483
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
477
478
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
475
476
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
473
474
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
468
469
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
466
467
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
465
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
33
45
.
Hans G. Drexler. 2001. The Leukemia-Lymphoma Cell Line FactsBook. The Leukemia-Lymphoma Cell Line FactsBook
12
21
.
Hans G Drexler, Yoshinobu Matsuo & Roderick A.F MacLeod. (2000) Continuous hematopoietic cell lines as model systems for leukemia–lymphoma research. Leukemia Research 24:11, pages 881-911.
Crossref
Crossref
Cordula Bittner, Alfred C Feller, Jean C Renauld, Karin Lange, Roman Pietrzik, Christine Jenetzky, Juliane Briese, Timo Gaiser, Anke Müller, Guenther J Wiedemann, Jaques Van Snick & Hartmut Merz. (2000) An Animal Model for Anaplastic Large Cell Lymphoma in the Immunocompetent Syngeneic C57Bl/6 Mouse. Laboratory Investigation 80:10, pages 1523-1531.
Crossref
Crossref
Qian Zhang, Puthiyaveettil N. Raghunath, Eric Vonderheid, Niels Ødum & Mariusz A. Wasik. (2000) Lack of Phosphotyrosine Phosphatase SHP-1 Expression in Malignant T-Cell Lymphoma Cells Results from Methylation of the SHP-1 Promoter. The American Journal of Pathology 157:4, pages 1137-1146.
Crossref
Crossref
HG Drexler, SM Gignac, R von Wasielewski, M Werner & WG Dirks. (2000) Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 14:9, pages 1533-1559.
Crossref
Crossref
Volkhard SeitzMichael HummelTheresa MarafiotiIoannis AnagnostopoulosChalid AssafHarald Stein. (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95:10, pages 3020-3024.
Crossref
Crossref
Volkhard SeitzMichael HummelTheresa MarafiotiIoannis AnagnostopoulosChalid AssafHarald Stein. (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95:10, pages 3020-3024.
Crossref
Crossref
Marshall E. Kadin. (2000) Regulation of CD30 Antigen Expression and Its Potential Significance for Human Disease. The American Journal of Pathology 156:5, pages 1479-1484.
Crossref
Crossref
Berit Jungnickel, Andrea Staratschek-Jox, Andreas Bräuninger, Tilmann Spieker, Jürgen Wolf, Volker Diehl, Martin-Leo Hansmann, Klaus Rajewsky & Ralf Küppers. (2000) Clonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's Lymphoma. The Journal of Experimental Medicine 191:2, pages 395-402.
Crossref
Crossref
Louis M. Staudt. (2000) The Molecular and Cellular Origins of Hodgkin's Disease. The Journal of Experimental Medicine 191:2, pages 207-212.
Crossref
Crossref
Franziska JundtIoannis AnagnostopoulosKurt BommertFlorian EmmerichGerd MüllerHans-Dieter FossHans-Dieter RoyerHarald SteinBernd Dörken. (1999) Hodgkin/Reed-Sternberg Cells Induce Fibroblasts to Secrete Eotaxin, a Potent Chemoattractant for T Cells and Eosinophils. Blood 94:6, pages 2065-2071.
Crossref
Crossref
Franziska JundtIoannis AnagnostopoulosKurt BommertFlorian EmmerichGerd MüllerHans-Dieter FossHans-Dieter RoyerHarald SteinBernd Dörken. (1999) Hodgkin/Reed-Sternberg Cells Induce Fibroblasts to Secrete Eotaxin, a Potent Chemoattractant for T Cells and Eosinophils. Blood 94:6, pages 2065-2071.
Crossref
Crossref
Manuel Montesinos-RongenAxel RoersRalf KüppersKlaus RajewskyMartin-Leo Hansmann. (1999) Mutation of the p53 Gene Is Not a Typical Feature of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Disease. Blood 94:5, pages 1755-1760.
Crossref
Crossref
Manuel Montesinos-RongenAxel RoersRalf KüppersKlaus RajewskyMartin-Leo Hansmann. (1999) Mutation of the p53 Gene Is Not a Typical Feature of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Disease. Blood 94:5, pages 1755-1760.
Crossref
Crossref
Jeffrey CossmanChristina M. AnnunziataSteven BarashLouis StaudtPatrick DillonWei-Wu HePaola Ricciardi-CastagnoliCraig A. RosenKenneth C. Carter. (1999) Reed-Sternberg Cell Genome Expression Supports a B-Cell Lineage. Blood 94:2, pages 411-416.
Crossref
Crossref
Jeffrey CossmanChristina M. AnnunziataSteven BarashLouis StaudtPatrick DillonWei-Wu HePaola Ricciardi-CastagnoliCraig A. RosenKenneth C. Carter. (1999) Reed-Sternberg Cell Genome Expression Supports a B-Cell Lineage. Blood 94:2, pages 411-416.
Crossref
Crossref
Ursula Kapp, Wen-Chen Yeh, Bruce Patterson, Andrew J. Elia, David Kägi, Alexandra Ho, Andrew Hessel, Mike Tipsword, Alexia Williams, Christine Mirtsos, Annick Itie, Matthew Moyle & Tak W. Mak. (1999) Interleukin 13 Is Secreted by and Stimulates the Growth of Hodgkin and Reed-Sternberg Cells. The Journal of Experimental Medicine 189:12, pages 1939-1946.
Crossref
Crossref
Eric Cabannes, Gulfaraz Khan, Fabienne Aillet, Ruth F Jarrett & Ronald T Hay. (1999) Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene 18:20, pages 3063-3070.
Crossref
Crossref
Isao SakumaTadashi YoshinoKunihiro OmonishiRitsuo NishiuchiNorihiro TeramotoHiroyuki YanaiKunimitsu KawaharaIchiro KubonishiYoshinobu Matsuo & Tadaatsu Akagi. (2002) CD95 ligand is expressed in Reed–Sternberg cells of Hodgkin’s disease. Pathology International 49:2, pages 103-109.
Crossref
Crossref
H.J. Wagner, F. Klintworth, W. Jabs, K. Lange, B. Schlegelberger, L. Harder, A.C. Feller & P. Bucsky. (1998) Characterization of the novel, pediatric Hodgkin disease-derived cell line HKB-1. Medical and Pediatric Oncology 31:3, pages 138-143.
Crossref
Crossref
Steven P. LeeChristothea M. ConstandinouWendy A. ThomasDebbie Croom-CarterNeil W. BlakePaul G. MurrayJohn CrockerAlan B. Rickinson. (1998) Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition. Blood 92:3, pages 1020-1030.
Crossref
Crossref
Steven P. LeeChristothea M. ConstandinouWendy A. ThomasDebbie Croom-CarterNeil W. BlakePaul G. MurrayJohn CrockerAlan B. Rickinson. (1998) Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition. Blood 92:3, pages 1020-1030.
Crossref
Crossref
Ilse Christiansen, Christer SundstrÖm, Gunilla Enblad & Thomas H. Tötterman. (2008) Soluble vascular cell adhesion molecule‐1 (sVCAM‐1) is an independent prognostic marker in Hodgkin's disease. British Journal of Haematology 102:3, pages 701-709.
Crossref
Crossref
Lorenzo Leoncini, Tiziana Megha, Stefano Lazzi, Cristiana Bellan, Pietro Luzi, Piero Tosi, Gabriele Cevenini, Paolo Barbini, Stefano Ascani, Aspasia Briskomatis, Stefano Pileri, Rainer Kraft, Jean A. Laissue & Hans Cottier. (1998) Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: Relation to the expression of p34cdc2 and cyclin B-1. International Journal of Cancer 77:3, pages 408-414.
Crossref
Crossref
Karl-Fredrik NorrbackGunilla EnbladMartin ErlansonChrister SundströmGöran Roos. (1998) Telomerase Activity in Hodgkin's Disease. Blood 92:2, pages 567-573.
Crossref
Crossref
Karl-Fredrik NorrbackGunilla EnbladMartin ErlansonChrister SundströmGöran Roos. (1998) Telomerase Activity in Hodgkin's Disease. Blood 92:2, pages 567-573.
Crossref
Crossref
Ralf KüppersKlaus Rajewsky. (1998) THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE. Annual Review of Immunology 16:1, pages 471-493.
Crossref
Crossref
Andrea Jox, Jürgen Wolf & Volker Diehl. (1997) Hodgkin's disease biology: recent advances. Hematological Oncology 15:4, pages 165-171.
Crossref
Crossref
Antonino CarboneAnnunziata GloghiniValter GatteiMassimo DeganSalvatore ImprotaDonatella AldinucciVincenzo CanzonieriTiziana PerinRachele VolpeGianluca GaidanoVittorina ZagonelAntonio Pinto. (1997) Reed-Sternberg Cells of Classical Hodgkin's Disease React With the Plasma Cell-Specific Monoclonal Antibody B-B4 and Express Human Syndecan-1. Blood 89:10, pages 3787-3794.
Crossref
Crossref
Antonino CarboneAnnunziata GloghiniValter GatteiMassimo DeganSalvatore ImprotaDonatella AldinucciVincenzo CanzonieriTiziana PerinRachele VolpeGianluca GaidanoVittorina ZagonelAntonio Pinto. (1997) Reed-Sternberg Cells of Classical Hodgkin's Disease React With the Plasma Cell-Specific Monoclonal Antibody B-B4 and Express Human Syndecan-1. Blood 89:10, pages 3787-3794.
Crossref
Crossref
A. Pinto, D. Aldinucci, A. Gloghini, A. Zagonel, M. Degan, V. Perin, M. Todesco, A. De Iuliis, S. Improta, C. Sacco, V. Gattei, H.-J. Gruss & A. Carbone. (1997) The role of eosinophils in the pathobiology of Hodgkin's disease. Annals of Oncology 8, pages S89-S96.
Crossref
Crossref
A. Jox, J. Wolf & V. Diehl. 1997. Maligne Lymphome. Maligne Lymphome
89
97
.
Hans-Jürgen Gruss & Marshall E. Kadin. (1996) 2 Pathophysiology of Hodgkin's disease: functional and molecular aspects. Baillière's Clinical Haematology 9:3, pages 417-446.
Crossref
Crossref
M. Küpper, U. Loftin, F. von Bonin, A. Gause, M. Pfreundschuh, H. Daus & L. Trümper. (1996) Single cell PCR for the analysis of Hodgkin's disease: Four years later. Annals of Oncology 7, pages S35-S39.
Crossref
Crossref
R. Küppers, H. Kanzler, M.-L. Hansmann & K. Rajewsky. (1996) Single cell analysis of Hodgkin/Reed–Sternberg cells. Annals of Oncology 7, pages S27-S30.
Crossref
Crossref
Hans‐Jürgen Gruss, Dawn Ulrich, Steve Braddy, Richard J. Armitage & Steven K. Dower. (2005) Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed‐Sternberg cells. European Journal of Immunology 25:7, pages 2083-2089.
Crossref
Crossref
Ursula Kapp, Jürgen Wolf, Christof von Kalle & Volker Diehl. 1995. Etiology of Hodgkin’s Disease. Etiology of Hodgkin’s Disease
173
186
.
Hans-Jürgen. Gruss & Steven. K. Dower. 1996. Etiology of Hodgkin’s Disease. Etiology of Hodgkin’s Disease
127
141
.
Antonino Carbone, Marzia Cozzi, Annunziata Gloghini & Antonio Pinto. (1994) CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Human Pathology 25:12, pages 1360-1365.
Crossref
Crossref
Hans G. Drexler, Suzanne M. Gignac & Jun Minowada. 1994. Atlas of Human Tumor Cell Lines. Atlas of Human Tumor Cell Lines
213
250
.